DAVID P SOUTHWELL Insider Trading Transactions
Get free email notifications about insider trading for DAVID P SOUTHWELL.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of DAVID P SOUTHWELL. DAVID P SOUTHWELL is Director in HUMAN GENOME SCIENCES INC ($HGSI) and Chief Financial Officer in Sunovion Pharmaceuticals Inc. ($SEPR) and Executive VP and CEO in Sunovion Pharmaceuticals Inc. ($SEPR) and Executive VP and CFO in Sunovion Pharmaceuticals Inc. ($SEPR) and in ROCKET PHARMACEUTICALS, INC. ($RCKT) and Director in ROCKET PHARMACEUTICALS, INC. ($RCKT) and President and CEO in INOTEK PHARMACEUTICALS CORP ($ITEK) and See Remarks in INOTEK PHARMACEUTICALS CORP ($ITEK) and Director in PTC THERAPEUTICS, INC. ($PTCT) and Director in Spero Therapeutics, Inc. ($SPRO).
Latest Insider Trading Transactions of DAVID P SOUTHWELL
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, HGSI, PTCT, RCKT, SPRO, SEPR
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 16 2021 | RCKT | ROCKET PHARMACEUTI ... | SOUTHWELL DAVID P | Option Exercise | A | 47.25 | 12,236 | 578,151 | 12,236 | ||
Jan 08 2021 | PTCT | PTC THERAPEUTICS, ... | SOUTHWELL DAVID P | Director | Option Exercise | A | 66.49 | 10,000 | 664,900 | 10,000 | |
Jan 08 2021 | PTCT | PTC THERAPEUTICS, ... | SOUTHWELL DAVID P | Director | Grant | A | 0.00 | 1,650 | 0 | 3,300 | 1.7 K to 3.3 K (+100.00 %) |
Oct 20 2020 | PTCT | PTC THERAPEUTICS, ... | SOUTHWELL DAVID P | Director | Option Exercise | M | 11.23 | 12,000 | 134,760 | 0 | |
Oct 20 2020 | PTCT | PTC THERAPEUTICS, ... | SOUTHWELL DAVID P | Director | Option Exercise | M | 10.85 | 15,000 | 162,750 | 0 | |
Oct 20 2020 | PTCT | PTC THERAPEUTICS, ... | SOUTHWELL DAVID P | Director | Sell | S | 52.18 | 500 | 26,089 | 1,650 | 2.2 K to 1.7 K (-23.26 %) |
Oct 20 2020 | PTCT | PTC THERAPEUTICS, ... | SOUTHWELL DAVID P | Director | Sell | S | 51.52 | 11,500 | 592,434 | 2,150 | 13.7 K to 2.2 K (-84.25 %) |
Oct 20 2020 | PTCT | PTC THERAPEUTICS, ... | SOUTHWELL DAVID P | Director | Buy | M | 11.23 | 12,000 | 134,760 | 13,650 | 1.7 K to 13.7 K (+727.27 %) |
Oct 20 2020 | PTCT | PTC THERAPEUTICS, ... | SOUTHWELL DAVID P | Director | Sell | S | 52.18 | 700 | 36,528 | 1,650 | 2.4 K to 1.7 K (-29.79 %) |
Oct 20 2020 | PTCT | PTC THERAPEUTICS, ... | SOUTHWELL DAVID P | Director | Sell | S | 51.50 | 14,300 | 736,493 | 2,350 | 16.7 K to 2.4 K (-85.89 %) |
Oct 20 2020 | PTCT | PTC THERAPEUTICS, ... | SOUTHWELL DAVID P | Director | Buy | M | 10.85 | 15,000 | 162,750 | 16,650 | 1.7 K to 16.7 K (+909.09 %) |
Jun 18 2020 | RCKT | ROCKET PHARMACEUTI ... | SOUTHWELL DAVID P | Option Exercise | A | 19.90 | 20,000 | 398,000 | 20,000 | ||
Jun 18 2020 | RCKT | ROCKET PHARMACEUTI ... | SOUTHWELL DAVID P | Option Exercise | A | 19.90 | 20,000 | 398,000 | 20,000 | ||
Jan 31 2020 | PTCT | PTC THERAPEUTICS, ... | SOUTHWELL DAVID P | Director | Option Exercise | A | 51.16 | 10,000 | 511,600 | 10,000 | |
Jan 31 2020 | PTCT | PTC THERAPEUTICS, ... | SOUTHWELL DAVID P | Director | Grant | A | 0.00 | 1,650 | 0 | 1,650 | 0 to 1.7 K |
Jan 30 2019 | RCKT | ROCKET PHARMACEUTI ... | SOUTHWELL DAVID P | Option Exercise | A | 14.56 | 30,000 | 436,800 | 30,000 | ||
Jan 24 2019 | PTCT | PTC THERAPEUTICS, ... | SOUTHWELL DAVID P | Director | Option Exercise | A | 33.02 | 14,000 | 462,280 | 14,000 | |
Dec 14 2018 | RCKT | ROCKET PHARMACEUTI ... | SOUTHWELL DAVID P | Sell | S | 15.19 | 38,768 | 588,886 | 95,160 | 133.9 K to 95.2 K (-28.95 %) | |
Dec 10 2018 | RCKT | ROCKET PHARMACEUTI ... | SOUTHWELL DAVID P | Option Exercise | M | 0.00 | 65,625 | 0 | 0 | ||
Dec 10 2018 | RCKT | ROCKET PHARMACEUTI ... | SOUTHWELL DAVID P | Sell | S | 14.91 | 4,923 | 73,402 | 133,928 | 138.9 K to 133.9 K (-3.55 %) | |
Dec 10 2018 | RCKT | ROCKET PHARMACEUTI ... | SOUTHWELL DAVID P | Sell | S | 15.15 | 52,809 | 800,056 | 138,851 | 191.7 K to 138.9 K (-27.55 %) | |
Dec 10 2018 | RCKT | ROCKET PHARMACEUTI ... | SOUTHWELL DAVID P | Buy | M | 0.00 | 153,125 | 0 | 191,660 | 38.5 K to 191.7 K (+397.37 %) | |
Jun 06 2018 | SPRO | Spero Therapeutics ... | SOUTHWELL DAVID P | Director | Option Exercise | A | 11.54 | 6,073 | 70,082 | 6,073 | |
Apr 02 2018 | RCKT | ROCKET PHARMACEUTI ... | SOUTHWELL DAVID P | Director | Option Exercise | M | 0.00 | 21,875 | 0 | 65,625 | |
Apr 02 2018 | RCKT | ROCKET PHARMACEUTI ... | SOUTHWELL DAVID P | Director | Option Exercise | A | 18.75 | 40,000 | 750,000 | 40,000 | |
Apr 02 2018 | RCKT | ROCKET PHARMACEUTI ... | SOUTHWELL DAVID P | Director | Buy | M | 0.00 | 21,875 | 0 | 38,535 | 16.7 K to 38.5 K (+131.30 %) |
Mar 30 2018 | SPRO | Spero Therapeutics ... | SOUTHWELL DAVID P | Director | Option Exercise | A | 14.25 | 12,146 | 173,081 | 12,146 | |
Jan 05 2018 | PTCT | PTC THERAPEUTICS, ... | SOUTHWELL DAVID P | Director | Option Exercise | A | 18.01 | 14,000 | 252,140 | 14,000 | |
Jan 24 2017 | ITEK | INOTEK PHARMACEUTI ... | SOUTHWELL DAVID P | President and CEO | Option Exercise | A | 0.00 | 350,000 | 0 | 350,000 | |
Jan 24 2017 | ITEK | INOTEK PHARMACEUTI ... | SOUTHWELL DAVID P | President and CEO | Option Exercise | A | 0.00 | 350,000 | 0 | 350,000 | |
Jan 09 2017 | ITEK | INOTEK PHARMACEUTI ... | SOUTHWELL DAVID P | President and CEO | Buy | P | 1.75 | 60,000 | 105,000 | 62,765 | 2.8 K to 62.8 K (+2,169.98 %) |
Jan 09 2017 | PTCT | PTC THERAPEUTICS, ... | SOUTHWELL DAVID P | Director | Option Exercise | A | 11.23 | 12,000 | 134,760 | 12,000 | |
Mar 24 2016 | ITEK | INOTEK PHARMACEUTI ... | SOUTHWELL DAVID P | See Remarks | Option Exercise | A | 7.56 | 215,000 | 1,625,400 | 215,000 | |
Jan 06 2016 | PTCT | PTC THERAPEUTICS, ... | SOUTHWELL DAVID P | Director | Option Exercise | A | 30.86 | 12,000 | 370,320 | 12,000 | |
Jul 06 2015 | PTCT | PTC THERAPEUTICS, ... | SOUTHWELL DAVID P | Director | Option Exercise | M | 10.85 | 15,000 | 162,750 | 15,000 | |
Jul 06 2015 | PTCT | PTC THERAPEUTICS, ... | SOUTHWELL DAVID P | Director | Sell | S | 48.22 | 700 | 33,754 | 0 | 700 to 0 (-100.00 %) |
Jul 06 2015 | PTCT | PTC THERAPEUTICS, ... | SOUTHWELL DAVID P | Director | Sell | S | 47.50 | 22,904 | 1,087,940 | 700 | 23.6 K to 700 (-97.03 %) |
Jul 06 2015 | PTCT | PTC THERAPEUTICS, ... | SOUTHWELL DAVID P | Director | Buy | M | 10.85 | 15,000 | 162,750 | 23,604 | 8.6 K to 23.6 K (+174.34 %) |
Jun 26 2015 | ITEK | INOTEK PHARMACEUTI ... | SOUTHWELL DAVID P | See Remarks | Option Exercise | A | 5.03 | 150,000 | 754,500 | 548,497 | |
Mar 23 2015 | PTCT | PTC THERAPEUTICS, ... | SOUTHWELL DAVID P | Director | Sell | S | 69.91 | 117 | 8,179 | 8,604 | 8.7 K to 8.6 K (-1.34 %) |
Mar 23 2015 | PTCT | PTC THERAPEUTICS, ... | SOUTHWELL DAVID P | Director | Sell | S | 68.99 | 2,200 | 151,778 | 8,721 | 10.9 K to 8.7 K (-20.14 %) |
Jul 24 2008 | HGSI | HUMAN GENOME SCIEN ... | SOUTHWELL DAVID P | Director | Option Exercise | A | 7.00 | 25,000 | 175,000 | 25,000 | |
May 17 2007 | SEPR | Sunovion Pharmaceu ... | SOUTHWELL DAVID P | Chief Financial Off ... | Option Exercise | A | 53.35 | 25,000 | 1,333,750 | 757,750 | |
May 17 2007 | SEPR | Sunovion Pharmaceu ... | SOUTHWELL DAVID P | Chief Financial Off ... | Grant | A | 53.35 | 17,500 | 933,625 | 59,702 | 42.2 K to 59.7 K (+41.47 %) |
Mar 09 2007 | SEPR | Sunovion Pharmaceu ... | SOUTHWELL DAVID P | Chief Financial Off ... | Option Exercise | A | 27.00 | 77,500 | 2,092,500 | 732,750 | |
Mar 09 2007 | SEPR | Sunovion Pharmaceu ... | SOUTHWELL DAVID P | Chief Financial Off ... | Option Exercise | D | 24.54 | 77,500 | 1,901,850 | 655,250 | |
Mar 09 2007 | SEPR | Sunovion Pharmaceu ... | SOUTHWELL DAVID P | Chief Financial Off ... | Option Exercise | A | 24.31 | 316,000 | 7,681,960 | 732,750 | |
Mar 09 2007 | SEPR | Sunovion Pharmaceu ... | SOUTHWELL DAVID P | Chief Financial Off ... | Option Exercise | D | 18.38 | 316,000 | 5,808,080 | 416,750 | |
Mar 09 2007 | SEPR | Sunovion Pharmaceu ... | SOUTHWELL DAVID P | Chief Financial Off ... | Option Exercise | A | 19.31 | 2,000 | 38,620 | 732,750 | |
Mar 09 2007 | SEPR | Sunovion Pharmaceu ... | SOUTHWELL DAVID P | Chief Financial Off ... | Option Exercise | D | 12.12 | 2,000 | 24,240 | 730,750 | |
Mar 20 2006 | SEPR | Sunovion Pharmaceu ... | SOUTHWELL DAVID P | Chief Financial Off ... | Option Exercise | A | 55.54 | 17,250 | 958,065 | 807,750 | |
Mar 20 2006 | SEPR | Sunovion Pharmaceu ... | SOUTHWELL DAVID P | Chief Financial Off ... | Grant | A | 55.54 | 3,800 | 211,052 | 42,202 | 38.4 K to 42.2 K (+9.90 %) |
Mar 20 2006 | SEPR | Sunovion Pharmaceu ... | SOUTHWELL DAVID P | Chief Financial Off ... | Grant | A | 55.54 | 11,500 | 638,710 | 38,402 | 26.9 K to 38.4 K (+42.75 %) |
Oct 27 2005 | SEPR | Sunovion Pharmaceu ... | SOUTHWELL DAVID P | Chief Financial Off ... | Option Exercise | M | 6.24 | 3 | 19 | 790,500 | |
Oct 27 2005 | SEPR | Sunovion Pharmaceu ... | SOUTHWELL DAVID P | Chief Financial Off ... | Option Exercise | M | 6.24 | 99,997 | 623,981 | 790,503 | |
Oct 27 2005 | SEPR | Sunovion Pharmaceu ... | SOUTHWELL DAVID P | Chief Financial Off ... | Sell | S | 56.85 | 7,500 | 426,375 | 26,902 | 34.4 K to 26.9 K (-21.80 %) |
Oct 27 2005 | SEPR | Sunovion Pharmaceu ... | SOUTHWELL DAVID P | Chief Financial Off ... | Sell | S | 56.85 | 10,000 | 568,450 | 34,402 | 44.4 K to 34.4 K (-22.52 %) |
Oct 27 2005 | SEPR | Sunovion Pharmaceu ... | SOUTHWELL DAVID P | Chief Financial Off ... | Sell | S | 56.77 | 5,000 | 283,850 | 44,402 | 49.4 K to 44.4 K (-10.12 %) |
Oct 27 2005 | SEPR | Sunovion Pharmaceu ... | SOUTHWELL DAVID P | Chief Financial Off ... | Sell | S | 56.77 | 7,500 | 425,738 | 49,402 | 56.9 K to 49.4 K (-13.18 %) |
Oct 27 2005 | SEPR | Sunovion Pharmaceu ... | SOUTHWELL DAVID P | Chief Financial Off ... | Sell | S | 56.76 | 10,000 | 567,600 | 56,902 | 66.9 K to 56.9 K (-14.95 %) |
Oct 27 2005 | SEPR | Sunovion Pharmaceu ... | SOUTHWELL DAVID P | Chief Financial Off ... | Sell | S | 56.75 | 10,000 | 567,500 | 66,902 | 76.9 K to 66.9 K (-13.00 %) |
Oct 27 2005 | SEPR | Sunovion Pharmaceu ... | SOUTHWELL DAVID P | Chief Financial Off ... | Sell | S | 56.55 | 7,500 | 424,125 | 76,902 | 84.4 K to 76.9 K (-8.89 %) |
Oct 27 2005 | SEPR | Sunovion Pharmaceu ... | SOUTHWELL DAVID P | Chief Financial Off ... | Sell | S | 56.54 | 10,000 | 565,400 | 84,402 | 94.4 K to 84.4 K (-10.59 %) |
Oct 27 2005 | SEPR | Sunovion Pharmaceu ... | SOUTHWELL DAVID P | Chief Financial Off ... | Sell | S | 56.51 | 2,500 | 141,275 | 94,402 | 96.9 K to 94.4 K (-2.58 %) |
Oct 27 2005 | SEPR | Sunovion Pharmaceu ... | SOUTHWELL DAVID P | Chief Financial Off ... | Sell | S | 56.50 | 5,000 | 282,500 | 96,902 | 101.9 K to 96.9 K (-4.91 %) |
Oct 27 2005 | SEPR | Sunovion Pharmaceu ... | SOUTHWELL DAVID P | Chief Financial Off ... | Sell | S | 56.48 | 25,000 | 1,412,000 | 101,902 | 126.9 K to 101.9 K (-19.70 %) |
Oct 27 2005 | SEPR | Sunovion Pharmaceu ... | SOUTHWELL DAVID P | Chief Financial Off ... | Buy | M | 6.24 | 100,000 | 624,000 | 126,902 | 26.9 K to 126.9 K (+371.72 %) |
Mar 10 2005 | SEPR | Sunovion Pharmaceu ... | SOUTHWELL DAVID P | Chief Financial Off ... | Gift | G | 60.26 | 709 | 42,724 | 670,289 | 671 K to 670.3 K (-0.11 %) |
Feb 28 2005 | SEPR | Sunovion Pharmaceu ... | SOUTHWELL DAVID P | Chief Financial Off ... | Option Exercise | A | 64.50 | 100,000 | 6,450,000 | 670,998 | |
Nov 09 2004 | SEPR | Sunovion Pharmaceu ... | SOUTHWELL DAVID P | Chief Financial Off ... | Gift | G | 47.45 | 4,214 | 199,954 | 570,998 | 575.2 K to 571 K (-0.73 %) |
Jul 16 2004 | SEPR | Sunovion Pharmaceu ... | SOUTHWELL DAVID P | Executive VP and CE ... | Gift | G | 49.92 | 265 | 13,229 | 575,212 | 575.5 K to 575.2 K (-0.05 %) |
May 27 2004 | SEPR | Sunovion Pharmaceu ... | SOUTHWELL DAVID P | Executive VP and CF ... | Buy | J | 44.05 | 52,000 | 2,290,600 | 575,477 | 523.5 K to 575.5 K (+9.93 %) |
May 13 2004 | SEPR | Sunovion Pharmaceu ... | SOUTHWELL DAVID P | Executive VP and CF ... | Sell | S | 46.99 | 1,200 | 56,388 | 575,477 | 576.7 K to 575.5 K (-0.21 %) |
May 13 2004 | SEPR | Sunovion Pharmaceu ... | SOUTHWELL DAVID P | Executive VP and CF ... | Sell | S | 46.98 | 1,562 | 73,383 | 576,677 | 578.2 K to 576.7 K (-0.27 %) |
May 13 2004 | SEPR | Sunovion Pharmaceu ... | SOUTHWELL DAVID P | Executive VP and CF ... | Sell | S | 46.97 | 2,338 | 109,816 | 578,239 | 580.6 K to 578.2 K (-0.40 %) |
May 13 2004 | SEPR | Sunovion Pharmaceu ... | SOUTHWELL DAVID P | Executive VP and CF ... | Sell | S | 46.96 | 100 | 4,696 | 580,577 | 580.7 K to 580.6 K (-0.02 %) |
May 13 2004 | SEPR | Sunovion Pharmaceu ... | SOUTHWELL DAVID P | Executive VP and CF ... | Sell | S | 46.94 | 800 | 37,552 | 580,677 | 581.5 K to 580.7 K (-0.14 %) |
May 13 2004 | SEPR | Sunovion Pharmaceu ... | SOUTHWELL DAVID P | Executive VP and CF ... | Sell | S | 46.93 | 4,100 | 192,413 | 581,477 | 585.6 K to 581.5 K (-0.70 %) |
May 13 2004 | SEPR | Sunovion Pharmaceu ... | SOUTHWELL DAVID P | Executive VP and CF ... | Sell | S | 46.92 | 5,600 | 262,752 | 585,577 | 591.2 K to 585.6 K (-0.95 %) |
May 13 2004 | SEPR | Sunovion Pharmaceu ... | SOUTHWELL DAVID P | Executive VP and CF ... | Sell | S | 46.91 | 1,000 | 46,910 | 591,177 | 592.2 K to 591.2 K (-0.17 %) |
May 13 2004 | SEPR | Sunovion Pharmaceu ... | SOUTHWELL DAVID P | Executive VP and CF ... | Sell | S | 46.89 | 300 | 14,067 | 592,177 | 592.5 K to 592.2 K (-0.05 %) |
May 13 2004 | SEPR | Sunovion Pharmaceu ... | SOUTHWELL DAVID P | Executive VP and CF ... | Sell | S | 46.88 | 3,455 | 161,970 | 592,477 | 595.9 K to 592.5 K (-0.58 %) |
May 13 2004 | SEPR | Sunovion Pharmaceu ... | SOUTHWELL DAVID P | Executive VP and CF ... | Sell | S | 46.87 | 1,145 | 53,666 | 595,932 | 597.1 K to 595.9 K (-0.19 %) |
May 13 2004 | SEPR | Sunovion Pharmaceu ... | SOUTHWELL DAVID P | Executive VP and CF ... | Sell | S | 46.86 | 692 | 32,427 | 597,077 | 597.8 K to 597.1 K (-0.12 %) |
May 13 2004 | SEPR | Sunovion Pharmaceu ... | SOUTHWELL DAVID P | Executive VP and CF ... | Sell | S | 46.85 | 4,008 | 187,775 | 597,769 | 601.8 K to 597.8 K (-0.67 %) |
May 13 2004 | SEPR | Sunovion Pharmaceu ... | SOUTHWELL DAVID P | Executive VP and CF ... | Sell | S | 46.84 | 2,800 | 131,152 | 601,777 | 604.6 K to 601.8 K (-0.46 %) |
May 13 2004 | SEPR | Sunovion Pharmaceu ... | SOUTHWELL DAVID P | Executive VP and CF ... | Sell | S | 46.82 | 300 | 14,046 | 604,577 | 604.9 K to 604.6 K (-0.05 %) |
May 13 2004 | SEPR | Sunovion Pharmaceu ... | SOUTHWELL DAVID P | Executive VP and CF ... | Sell | S | 46.81 | 500 | 23,405 | 604,877 | 605.4 K to 604.9 K (-0.08 %) |
May 13 2004 | SEPR | Sunovion Pharmaceu ... | SOUTHWELL DAVID P | Executive VP and CF ... | Sell | S | 46.80 | 1,600 | 74,880 | 605,377 | 607 K to 605.4 K (-0.26 %) |
May 13 2004 | SEPR | Sunovion Pharmaceu ... | SOUTHWELL DAVID P | Executive VP and CF ... | Sell | S | 46.79 | 100 | 4,679 | 606,977 | 607.1 K to 607 K (-0.02 %) |
May 13 2004 | SEPR | Sunovion Pharmaceu ... | SOUTHWELL DAVID P | Executive VP and CF ... | Sell | S | 46.77 | 400 | 18,708 | 607,077 | 607.5 K to 607.1 K (-0.07 %) |
May 13 2004 | SEPR | Sunovion Pharmaceu ... | SOUTHWELL DAVID P | Executive VP and CF ... | Sell | S | 46.76 | 3,000 | 140,280 | 607,477 | 610.5 K to 607.5 K (-0.49 %) |
May 13 2004 | SEPR | Sunovion Pharmaceu ... | SOUTHWELL DAVID P | Executive VP and CF ... | Sell | S | 46.74 | 745 | 34,821 | 610,477 | 611.2 K to 610.5 K (-0.12 %) |
May 13 2004 | SEPR | Sunovion Pharmaceu ... | SOUTHWELL DAVID P | Executive VP and CF ... | Option Exercise | M | 12.13 | 28,000 | 339,500 | 489,666 | |
May 13 2004 | SEPR | Sunovion Pharmaceu ... | SOUTHWELL DAVID P | Executive VP and CF ... | Option Exercise | M | 12.13 | 30,000 | 363,750 | 517,666 | |
May 13 2004 | SEPR | Sunovion Pharmaceu ... | SOUTHWELL DAVID P | Executive VP and CF ... | Option Exercise | M | 12.13 | 28,000 | 339,500 | 547,666 | |
May 13 2004 | SEPR | Sunovion Pharmaceu ... | SOUTHWELL DAVID P | Executive VP and CF ... | Sell | S | 46.72 | 745 | 34,806 | 611,222 | 612 K to 611.2 K (-0.12 %) |
May 13 2004 | SEPR | Sunovion Pharmaceu ... | SOUTHWELL DAVID P | Executive VP and CF ... | Sell | S | 46.70 | 5,000 | 233,500 | 611,967 | 617 K to 612 K (-0.81 %) |
May 13 2004 | SEPR | Sunovion Pharmaceu ... | SOUTHWELL DAVID P | Executive VP and CF ... | Sell | S | 46.69 | 2,800 | 130,732 | 616,967 | 619.8 K to 617 K (-0.45 %) |
May 13 2004 | SEPR | Sunovion Pharmaceu ... | SOUTHWELL DAVID P | Executive VP and CF ... | Sell | S | 46.68 | 120 | 5,602 | 619,767 | 619.9 K to 619.8 K (-0.02 %) |
May 13 2004 | SEPR | Sunovion Pharmaceu ... | SOUTHWELL DAVID P | Executive VP and CF ... | Sell | S | 46.67 | 1,330 | 62,071 | 619,887 | 621.2 K to 619.9 K (-0.21 %) |
May 13 2004 | SEPR | Sunovion Pharmaceu ... | SOUTHWELL DAVID P | Executive VP and CF ... | Sell | S | 46.66 | 3,045 | 142,080 | 621,217 | 624.3 K to 621.2 K (-0.49 %) |
May 13 2004 | SEPR | Sunovion Pharmaceu ... | SOUTHWELL DAVID P | Executive VP and CF ... | Sell | S | 46.64 | 200 | 9,328 | 624,262 | 624.5 K to 624.3 K (-0.03 %) |
May 13 2004 | SEPR | Sunovion Pharmaceu ... | SOUTHWELL DAVID P | Executive VP and CF ... | Sell | S | 46.63 | 5,425 | 252,968 | 624,462 | 629.9 K to 624.5 K (-0.86 %) |
May 13 2004 | SEPR | Sunovion Pharmaceu ... | SOUTHWELL DAVID P | Executive VP and CF ... | Sell | S | 46.61 | 400 | 18,644 | 629,887 | 630.3 K to 629.9 K (-0.06 %) |
May 13 2004 | SEPR | Sunovion Pharmaceu ... | SOUTHWELL DAVID P | Executive VP and CF ... | Sell | S | 46.60 | 190 | 8,854 | 630,287 | 630.5 K to 630.3 K (-0.03 %) |
May 13 2004 | SEPR | Sunovion Pharmaceu ... | SOUTHWELL DAVID P | Executive VP and CF ... | Sell | S | 46.52 | 500 | 23,260 | 630,477 | 631 K to 630.5 K (-0.08 %) |
May 13 2004 | SEPR | Sunovion Pharmaceu ... | SOUTHWELL DAVID P | Executive VP and CF ... | Sell | S | 46.50 | 4,163 | 193,580 | 630,977 | 635.1 K to 631 K (-0.66 %) |
May 13 2004 | SEPR | Sunovion Pharmaceu ... | SOUTHWELL DAVID P | Executive VP and CF ... | Sell | S | 46.45 | 200 | 9,290 | 635,140 | 635.3 K to 635.1 K (-0.03 %) |
May 13 2004 | SEPR | Sunovion Pharmaceu ... | SOUTHWELL DAVID P | Executive VP and CF ... | Sell | S | 46.42 | 37 | 1,718 | 635,340 | 635.4 K to 635.3 K (-0.01 %) |
May 13 2004 | SEPR | Sunovion Pharmaceu ... | SOUTHWELL DAVID P | Executive VP and CF ... | Sell | S | 46.41 | 100 | 4,641 | 635,377 | 635.5 K to 635.4 K (-0.02 %) |
May 13 2004 | SEPR | Sunovion Pharmaceu ... | SOUTHWELL DAVID P | Executive VP and CF ... | Sell | S | 46.29 | 50 | 2,315 | 635,477 | 635.5 K to 635.5 K (-0.01 %) |
May 13 2004 | SEPR | Sunovion Pharmaceu ... | SOUTHWELL DAVID P | Executive VP and CF ... | Sell | S | 46.28 | 700 | 32,396 | 635,527 | 636.2 K to 635.5 K (-0.11 %) |
May 13 2004 | SEPR | Sunovion Pharmaceu ... | SOUTHWELL DAVID P | Executive VP and CF ... | Sell | S | 46.27 | 3,650 | 168,886 | 636,227 | 639.9 K to 636.2 K (-0.57 %) |
May 13 2004 | SEPR | Sunovion Pharmaceu ... | SOUTHWELL DAVID P | Executive VP and CF ... | Sell | S | 46.26 | 600 | 27,756 | 639,877 | 640.5 K to 639.9 K (-0.09 %) |
May 13 2004 | SEPR | Sunovion Pharmaceu ... | SOUTHWELL DAVID P | Executive VP and CF ... | Sell | S | 46.25 | 5,000 | 231,250 | 640,477 | 645.5 K to 640.5 K (-0.77 %) |
May 13 2004 | SEPR | Sunovion Pharmaceu ... | SOUTHWELL DAVID P | Executive VP and CF ... | Sell | S | 46.20 | 2,000 | 92,400 | 645,477 | 647.5 K to 645.5 K (-0.31 %) |
May 13 2004 | SEPR | Sunovion Pharmaceu ... | SOUTHWELL DAVID P | Executive VP and CF ... | Sell | S | 46.09 | 1,600 | 73,744 | 647,477 | 649.1 K to 647.5 K (-0.25 %) |
May 13 2004 | SEPR | Sunovion Pharmaceu ... | SOUTHWELL DAVID P | Executive VP and CF ... | Sell | S | 46.06 | 3,400 | 156,604 | 649,077 | 652.5 K to 649.1 K (-0.52 %) |
May 13 2004 | SEPR | Sunovion Pharmaceu ... | SOUTHWELL DAVID P | Executive VP and CF ... | Sell | S | 46.00 | 3,000 | 138,000 | 652,477 | 655.5 K to 652.5 K (-0.46 %) |
May 13 2004 | SEPR | Sunovion Pharmaceu ... | SOUTHWELL DAVID P | Executive VP and CF ... | Sell | S | 45.95 | 600 | 27,570 | 655,477 | 656.1 K to 655.5 K (-0.09 %) |
May 13 2004 | SEPR | Sunovion Pharmaceu ... | SOUTHWELL DAVID P | Executive VP and CF ... | Sell | S | 45.94 | 2,172 | 99,782 | 656,077 | 658.2 K to 656.1 K (-0.33 %) |
May 13 2004 | SEPR | Sunovion Pharmaceu ... | SOUTHWELL DAVID P | Executive VP and CF ... | Sell | S | 45.93 | 200 | 9,186 | 658,249 | 658.4 K to 658.2 K (-0.03 %) |
May 13 2004 | SEPR | Sunovion Pharmaceu ... | SOUTHWELL DAVID P | Executive VP and CF ... | Sell | S | 45.87 | 28 | 1,284 | 658,449 | 658.5 K to 658.4 K (0.00 %) |
May 13 2004 | SEPR | Sunovion Pharmaceu ... | SOUTHWELL DAVID P | Executive VP and CF ... | Sell | S | 45.85 | 3,000 | 137,550 | 658,477 | 661.5 K to 658.5 K (-0.45 %) |
May 13 2004 | SEPR | Sunovion Pharmaceu ... | SOUTHWELL DAVID P | Executive VP and CF ... | Buy | M | 12.13 | 86,000 | 1,042,750 | 661,477 | 575.5 K to 661.5 K (+14.94 %) |
May 12 2004 | SEPR | Sunovion Pharmaceu ... | SOUTHWELL DAVID P | Executive VP and CF ... | Sell | S | 46.68 | 100 | 4,668 | 661,477 | 661.6 K to 661.5 K (-0.02 %) |
May 12 2004 | SEPR | Sunovion Pharmaceu ... | SOUTHWELL DAVID P | Executive VP and CF ... | Sell | S | 46.66 | 2,312 | 107,878 | 661,577 | 663.9 K to 661.6 K (-0.35 %) |
May 12 2004 | SEPR | Sunovion Pharmaceu ... | SOUTHWELL DAVID P | Executive VP and CF ... | Sell | S | 46.65 | 3,769 | 175,824 | 663,889 | 667.7 K to 663.9 K (-0.56 %) |
May 12 2004 | SEPR | Sunovion Pharmaceu ... | SOUTHWELL DAVID P | Executive VP and CF ... | Sell | S | 46.64 | 700 | 32,648 | 667,658 | 668.4 K to 667.7 K (-0.10 %) |
May 12 2004 | SEPR | Sunovion Pharmaceu ... | SOUTHWELL DAVID P | Executive VP and CF ... | Sell | S | 46.62 | 875 | 40,793 | 668,358 | 669.2 K to 668.4 K (-0.13 %) |
May 12 2004 | SEPR | Sunovion Pharmaceu ... | SOUTHWELL DAVID P | Executive VP and CF ... | Sell | S | 46.61 | 100 | 4,661 | 669,233 | 669.3 K to 669.2 K (-0.01 %) |
May 12 2004 | SEPR | Sunovion Pharmaceu ... | SOUTHWELL DAVID P | Executive VP and CF ... | Sell | S | 46.60 | 3,713 | 173,026 | 669,333 | 673 K to 669.3 K (-0.55 %) |
May 12 2004 | SEPR | Sunovion Pharmaceu ... | SOUTHWELL DAVID P | Executive VP and CF ... | Sell | S | 46.59 | 5,208 | 242,641 | 673,046 | 678.3 K to 673 K (-0.77 %) |
May 12 2004 | SEPR | Sunovion Pharmaceu ... | SOUTHWELL DAVID P | Executive VP and CF ... | Sell | S | 46.57 | 1,700 | 79,169 | 678,254 | 680 K to 678.3 K (-0.25 %) |
May 12 2004 | SEPR | Sunovion Pharmaceu ... | SOUTHWELL DAVID P | Executive VP and CF ... | Sell | S | 46.55 | 5,300 | 246,715 | 679,954 | 685.3 K to 680 K (-0.77 %) |
May 12 2004 | SEPR | Sunovion Pharmaceu ... | SOUTHWELL DAVID P | Executive VP and CF ... | Sell | S | 46.54 | 6,000 | 279,240 | 685,254 | 691.3 K to 685.3 K (-0.87 %) |
May 12 2004 | SEPR | Sunovion Pharmaceu ... | SOUTHWELL DAVID P | Executive VP and CF ... | Sell | S | 46.53 | 5,100 | 237,303 | 691,254 | 696.4 K to 691.3 K (-0.73 %) |
May 12 2004 | SEPR | Sunovion Pharmaceu ... | SOUTHWELL DAVID P | Executive VP and CF ... | Sell | S | 46.52 | 5,000 | 232,600 | 696,354 | 701.4 K to 696.4 K (-0.71 %) |
May 12 2004 | SEPR | Sunovion Pharmaceu ... | SOUTHWELL DAVID P | Executive VP and CF ... | Sell | S | 46.51 | 1,548 | 71,997 | 701,354 | 702.9 K to 701.4 K (-0.22 %) |
May 12 2004 | SEPR | Sunovion Pharmaceu ... | SOUTHWELL DAVID P | Executive VP and CF ... | Sell | S | 46.50 | 200 | 9,300 | 702,902 | 703.1 K to 702.9 K (-0.03 %) |
May 12 2004 | SEPR | Sunovion Pharmaceu ... | SOUTHWELL DAVID P | Executive VP and CF ... | Sell | S | 46.49 | 500 | 23,245 | 703,102 | 703.6 K to 703.1 K (-0.07 %) |
May 12 2004 | SEPR | Sunovion Pharmaceu ... | SOUTHWELL DAVID P | Executive VP and CF ... | Sell | S | 46.45 | 5,200 | 241,540 | 703,602 | 708.8 K to 703.6 K (-0.73 %) |
May 12 2004 | SEPR | Sunovion Pharmaceu ... | SOUTHWELL DAVID P | Executive VP and CF ... | Sell | S | 46.44 | 8,983 | 417,171 | 708,802 | 717.8 K to 708.8 K (-1.25 %) |
May 12 2004 | SEPR | Sunovion Pharmaceu ... | SOUTHWELL DAVID P | Executive VP and CF ... | Sell | S | 46.43 | 8,119 | 376,965 | 717,785 | 725.9 K to 717.8 K (-1.12 %) |
May 12 2004 | SEPR | Sunovion Pharmaceu ... | SOUTHWELL DAVID P | Executive VP and CF ... | Sell | S | 46.41 | 200 | 9,282 | 725,904 | 726.1 K to 725.9 K (-0.03 %) |
May 12 2004 | SEPR | Sunovion Pharmaceu ... | SOUTHWELL DAVID P | Executive VP and CF ... | Sell | S | 46.40 | 7,881 | 365,678 | 726,104 | 734 K to 726.1 K (-1.07 %) |
May 12 2004 | SEPR | Sunovion Pharmaceu ... | SOUTHWELL DAVID P | Executive VP and CF ... | Sell | S | 46.39 | 100 | 4,639 | 733,985 | 734.1 K to 734 K (-0.01 %) |
May 12 2004 | SEPR | Sunovion Pharmaceu ... | SOUTHWELL DAVID P | Executive VP and CF ... | Sell | S | 46.38 | 2,400 | 111,312 | 734,085 | 736.5 K to 734.1 K (-0.33 %) |
May 12 2004 | SEPR | Sunovion Pharmaceu ... | SOUTHWELL DAVID P | Executive VP and CF ... | Sell | S | 46.36 | 200 | 9,272 | 736,485 | 736.7 K to 736.5 K (-0.03 %) |